Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue — Trials · CancerIndex

Clinical trials

Registered studies

169 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 21
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 10%
Top sponsor: City of Hope Medical Center
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03680586	Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT Lymphoma	active not recruiting	Early Phase 1	25	M.D. Anderson Cancer CenterOTHER	1	Apr 15, 2026	clinicaltrials
NCT01239875	Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma	completed	Early Phase 1	16	Mayo ClinicOTHER	1	Jan 14, 2020	clinicaltrials